(Q53574446)

15 May 2018

title

Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma. (English)

1 reference

15 May 2018

1 reference

1 reference

Wenzel SE

1

1 reference

15 May 2018

Lumry W

2

1 reference

15 May 2018

Manning M

3

1 reference

15 May 2018

Kalberg C

4

1 reference

15 May 2018

Cox F

5

1 reference

15 May 2018

Emmett A

6

1 reference

15 May 2018

Rickard K

7

1 reference

15 May 2018

publication date

1 June 1998

1 reference

15 May 2018

Annals of Allergy, Asthma & Immunology

published in

1 reference

15 May 2018

volume

80

1 reference

15 May 2018

issue

6

1 reference

15 May 2018

page(s)

463-470

1 reference

15 May 2018

Has the prevalence of asthma symptoms increased in Australian children?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

An economic evaluation of asthma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

A short exercise and living course for asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Developing outcome measures for ambulatory care--an application to asthma and diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

A measure of quality of life for clinical trials in chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Impairment, disability and handicap in chronic respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Quality-of-life considerations in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Measuring quality of life in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Performance of an asthma quality of life questionnaire in an outpatient setting

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Standardization of spirometry: a summary of recommendations from the American Thoracic Society. The 1987 update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963068-2

7 January 2021

10.1016/S1081-1206(10)63068-2

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018